Abstract:
Objective To investigate the correlation between the expression of β-arrestin2, calpain 2 and Hepatic Fibrosis in patients with Hepatitis B. Methods From January 2016 to April 2018, 102 CHB patients with liver biopsy were selected as CHB group. According to the degree of liver fiber, they were divided into mild hepatic fibrosis (46 cases) and severe hepatic fibrosis (30 cases). 26 cases of liver cirrhosis. 30 patients with liver transplantation were selected as control group. The expression levels of β-arrestin2 and calpain 2 mRNA and protein in liver tissues and the levels of serum HA, PC III, IV-C, LN were compared among the groups and the correlation analysis was carried out. Results The expression levels of β-arrestin2 and calpain 2 mRNA and protein in liver tissue in the CHB group were significantly higher than those in the control group (P<0.05). The serum levels of HA, PC III, IV-C, LN in CHB group were significantly higher than those in control group (P<0.05). The expression of β-arrestinin-2, calpain2 mRNA and the level of serum HA, PC III, IV-C, LN in patients with liver cirrhosis were significantly higher than those in mild and severe hepatic fibrosis (P<0.05). The expression of β-arrestinin-2, calpain2 mRNA and the level of serum HA, PC III, IV-C, LN in patients with severe hepatic fibrosis were significantly higher than those in mild hepatic fibrosis (P<0.05). By pearson correlation analysis, the expression of β-arrestinin-2, calpain2 mRNA was positively correlated with hepatic fibrosis index (P<0.05). Conclusion β-arrestinin-2, calpain2 mRNA is closely related to the degree of hepatic fiber in CHB patients, which may be a potential auxiliary index for the process of hepatic fibrosis.